10x Genomics Price to Book Ratio 2018-2026 | TXG
Historical price to book ratio values for 10x Genomics (TXG) over the last 10 years. The current price to book ratio for 10x Genomics as of September 16, 2026 is 11.74.
| 10x Genomics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 72.68 | 11.47 | |
| 2026-06-30 | 38.34 | $6.34 | 6.05 |
| 2026-03-31 | 21.23 | $6.61 | 3.21 |
| 2025-12-31 | 16.31 | $6.24 | 2.62 |
| 2025-09-30 | 11.69 | $6.20 | 1.88 |
| 2025-06-30 | 11.58 | $6.21 | 1.86 |
| 2025-03-31 | 8.73 | $5.74 | 1.52 |
| 2024-12-31 | 14.36 | $5.81 | 2.47 |
| 2024-09-30 | 22.58 | $5.97 | 3.78 |
| 2024-06-30 | 19.45 | $6.01 | 3.24 |
| 2024-03-31 | 37.53 | $6.00 | 6.25 |
| 2023-12-31 | 55.96 | $6.22 | 8.99 |
| 2023-09-30 | 41.25 | $6.30 | 6.54 |
| 2023-06-30 | 55.84 | $6.76 | 8.27 |
| 2023-03-31 | 55.79 | $6.91 | 8.08 |
| 2022-12-31 | 36.44 | $6.99 | 5.21 |
| 2022-09-30 | 28.48 | $6.96 | 4.09 |
| 2022-06-30 | 45.25 | $6.88 | 6.58 |
| 2022-03-31 | 76.07 | $7.12 | 10.68 |
| 2021-12-31 | 148.96 | $7.27 | 20.50 |
| 2021-09-30 | 145.58 | $7.17 | 20.29 |
| 2021-06-30 | 195.82 | $7.08 | 27.64 |
| 2021-03-31 | 181.00 | $6.87 | 26.36 |
| 2020-12-31 | 141.60 | $6.81 | 20.79 |
| 2020-09-30 | 124.68 | $7.81 | 15.96 |
| 2020-06-30 | 89.31 | $3.90 | 22.88 |
| 2020-03-31 | 62.32 | $4.17 | 14.95 |
| 2019-12-31 | 76.25 | $4.36 | 17.47 |
| 2019-09-30 | 50.40 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.692B | $0.643B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |